The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/27370
StudyName: Eligibility Cancer NCT00630110
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 09.11.2017
License: Creative Commons BY 4.0

----

Description: 
Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00630110
